Literature DB >> 9046957

Neuropsychiatric consequences of stroke.

R G Robinson1.   

Abstract

Numerous emotional and behavioral disorders occur following cerebrovascular lesions. Depression is the most common of these, affecting up to 40% of patients. Clinical correlates of post-stroke depression include severity of physical and cognitive impairment as well as location of brain injury. Perhaps the most compelling reason to identify post-stroke depression, however, is its substantial impact on recovery in activities of daily living, cognitive function, and survival. Antidepressant medication has been shown to effectively treat depression, although its administration may require careful clinical monitoring. Other post-stroke emotional/behavioral disorders include mania, bipolar disorder, anxiety disorder, apathy, and pathological crying. Controlled studies have not documented the effect of these disorders on long-term recovery, but the potential impact of syndromes such as mania and apathy on rehabilitation efforts or pathological crying on social functioning are evident. With the exception of pathological crying, which has been shown to respond to antidepressant drug therapy, the other post-stroke emotional/behavioral disorders need to be evaluated in controlled treatment trials for response to therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9046957     DOI: 10.1146/annurev.med.48.1.217

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  25 in total

1.  Cortical spreading depolarization increases adult neurogenesis, and alters behavior and hippocampus-dependent memory in mice.

Authors:  Anja Urbach; Eileen Baum; Falko Braun; Otto W Witte
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

2.  Mir363-3p attenuates post-stroke depressive-like behaviors in middle-aged female rats.

Authors:  Aditya Panta; Sivani Pandey; Irma N Duncan; Shaelynn Duhamel; Farida Sohrabji
Journal:  Brain Behav Immun       Date:  2019-01-10       Impact factor: 7.217

3.  Post Stroke Psychosis Following Lesions in Basal Ganglion.

Authors:  Shruti Srivastava; Mukul P Agarwal; Ankur Gautam
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

Authors:  Liborio Rampello; Santina Chiechio; Giovanni Nicoletti; Alessandro Alvano; Ignazio Vecchio; Rocco Raffaele; Mariano Malaguarnera
Journal:  Psychopharmacology (Berl)       Date:  2003-12-17       Impact factor: 4.530

5.  Emotional incontinence in Chinese stroke patients--diagnosis, frequency, and clinical and radiological correlates.

Authors:  Wai Kwong Tang; Sandra S M Chan; Helen F K Chiu; Gabor S Ungvari; Ka Sing Wong; Timothy C Y Kwok
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

6.  Post-stroke depression among stroke survivors attending two hospitals in Kampala Uganda.

Authors:  Joseph Ogavu Gyagenda; Edward Ddumba; Raymond Odokonyero; Mark Kaddumukasa; Martha Sajatovic; Kathyleen Smyth; Elly Katabira
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

7.  Mapping mania symptoms based on focal brain damage.

Authors:  Gonçalo Cotovio; Daniel Talmasov; J Bernardo Barahona-Corrêa; Joey Hsu; Suhan Senova; Ricardo Ribeiro; Louis Soussand; Ana Velosa; Vera Cruz E Silva; Natalia Rost; Ona Wu; Alexander L Cohen; Albino J Oliveira-Maia; Michael D Fox
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

8.  Management of depression in elderly stroke patients.

Authors:  Johan Lökk; Ahmad Delbari
Journal:  Neuropsychiatr Dis Treat       Date:  2010-09-07       Impact factor: 2.570

9.  Poststroke Neuropsychiatric Illness: An Integrated Approach to Diagnosis and Management.

Authors:  James A. Bourgeois; Donald M. Hilty; Celia H. Chang; Mark A. Wineinger; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

Review 10.  The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.

Authors:  Patrick E McKnight; Todd B Kashdan
Journal:  Clin Psychol Rev       Date:  2009-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.